仙灵化成（厦门）生物医药科技有限公司成立，注册资本5000万人民币

Company Overview - Xianling Huacheng (Xiamen) Biomedical Technology Co., Ltd. has been established with a registered capital of 50 million RMB [1] - The legal representative of the company is FANYU, and the shareholders include Beijing Hecheng Hesheng Biotechnology Co., Ltd. (55%), FANYU (30%), and Yikang Zhili (Xiamen) Health Management Co., Ltd. (15%) [1] Business Scope - The company’s business scope includes medical research and experimental development (excluding human stem cells, gene diagnosis, and treatment technology development and application) [1] - It also covers the research and development of biochemistry products, engineering and technology research and experimental development, natural science research, agricultural science research, and various technology services [1] - The company is involved in the sale of chemical products (excluding licensed chemical products), import and export of goods, and technology promotion and application services [1] Licensing and Regulatory Compliance - The company is authorized to engage in drug production, wholesale, import and export, and entrusted production of drugs, subject to approval by relevant authorities [1] - The business activities are conducted in accordance with the business license and relevant regulatory approvals [1]